Regenxbio schedules conference call to discuss second-quarter results and operational update
RGNX•Conference call details
- Regenxbio schedules an Aug. 6 conference call at 8:00 a.m. ET to review Q2 2026 results, ended June 30, 2026.
- Webcast registration: https://edge.media-server.com/mmc/p/78etmvqh.
- Analyst Q&A registration: https://registrations.events/direct/NTM255895.
